Congressman Gonzalez Applauds New Medicare Drug Pricing Rule Aimed at Lowering Prescription Drug Prices

Translate to Spanish or other 102 languages!

The new rule includes language from Congressman Gonzalez’s PHAIR Pricing Act

Mega Doctor News

- Advertisement -

WASHINGTON – Congressman Vicente Gonzalez (TX-15) today announced that the Centers for Medicare and Medicaid Services has issued a proposed rule that lowers prescription drug costs and increases transparency surrounding Medicare Parts C and D.

In May 2018, Congressmen Gonzalez and Doug Collins (GA-09) introduced the bipartisan H.R. 5958, the PHAIR Pricing Act of 2018, to lower drug costs to Medicare recipients at the point of sale. The new rule includes language from this bill.

“Medicare recipients deserve transparency,” Congressman Gonzalez said. “Prescription drug prices should not be decided behind a curtain and the final cost should not be equal to almost 50 percent above the negotiated price. The road to fixing America’s prescription drug market may be long, but I commend the Centers for Medicare and Medicaid Services for taking this important step.”

- Advertisement -

Congressman Gonzalez has pledged to make it his mission in Congress to make affordable, accessible healthcare and prescription drugs readily available to Central and South Texans.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

STHS Children’s Marks 20th Anniversary with Gala Honoring Pediatric Providers Behind Its Success

For the past 20 years, South Texas Health System Children’s has stood as a place where compassionate care and clinical excellence come together to create hope for children and their families.
- Advertisement -